Literature DB >> 35441976

Non-antibiotic Approaches to Preventing Pediatric UTIs: a Role for D-Mannose, Cranberry, and Probiotics?

Christina B Ching1.   

Abstract

PURPOSE OF REVIEW: While antibiotics have been a staple in the management and even prevention of urinary tract infections (UTIs), it is not without significant consequences due to intolerance and development of antibiotic resistant bacteria. These concerns necessitate alternatives to antibiotic use in the management of pediatric UTIs. This review seeks to evaluate non-antibiotic means of preventing UTI in the pediatric population. RECENT
FINDINGS: The search for preventative alternatives to antibiotics has included D-mannose, cranberry, and probiotics. These products similarly work through competitive inhibition of uropathogens in the urinary tract. Pediatric studies exist highlighting the use of cranberry extract/juice and probiotics in UTI prevention, although significant heterogeneity amongst studies have limited overarching recommendations for their use. Data of D-mannose use is extrapolated from adult literature. More studies are required in the utility of each treatment, with some emphasis on larger sample sizes and clarifications regarding dosing and formulation.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Cranberry; D-mannose; Pediatric; Proanthocyanidin; Probiotics; Urinary tract infection

Mesh:

Substances:

Year:  2022        PMID: 35441976     DOI: 10.1007/s11934-022-01094-w

Source DB:  PubMed          Journal:  Curr Urol Rep        ISSN: 1527-2737            Impact factor:   3.092


  75 in total

1.  Morbidity, age and sex distribution, recurrences and renal scarring in symptomatic urinary tract infection in childhood.

Authors:  J Winberg; T Bergström; B Jacobsson
Journal:  Kidney Int Suppl       Date:  1975-08       Impact factor: 10.545

2.  Risk factors for recurrent urinary tract infection in preschool children.

Authors:  K Panaretto; J Craig; J Knight; R Howman-Giles; P Sureshkumar; L Roy
Journal:  J Paediatr Child Health       Date:  1999-10       Impact factor: 1.954

Review 3.  Drug-resistant gram-negative uropathogens: A review.

Authors:  Saeed Khoshnood; Mohsen Heidary; Reza Mirnejad; Aghil Bahramian; Mansour Sedighi; Habibollah Mirzaei
Journal:  Biomed Pharmacother       Date:  2017-08-12       Impact factor: 6.529

4.  Recurrence and follow-up after urinary tract infection under the age of 1 year.

Authors:  M Nuutinen; M Uhari
Journal:  Pediatr Nephrol       Date:  2001-01       Impact factor: 3.714

5.  Development of hypertension and uraemia after pyelonephritis in childhood: 27 year follow up.

Authors:  S H Jacobson; O Eklöf; C G Eriksson; L E Lins; B Tidgren; J Winberg
Journal:  BMJ       Date:  1989-09-16

6.  Pediatric urinary tract infections: an analysis of hospitalizations, charges, and costs in the USA.

Authors:  John David Spencer; Andrew Schwaderer; Kirk McHugh; David S Hains
Journal:  Pediatr Nephrol       Date:  2010-08-14       Impact factor: 3.714

7.  Antibiotic prophylaxis and recurrent urinary tract infection in children.

Authors:  Jonathan C Craig; Judy M Simpson; Gabrielle J Williams; Alison Lowe; Graham J Reynolds; Steven J McTaggart; Elisabeth M Hodson; Jonathan R Carapetis; Noel E Cranswick; Grahame Smith; Les M Irwig; Patrina H Y Caldwell; Sana Hamilton; Leslie P Roy
Journal:  N Engl J Med       Date:  2009-10-29       Impact factor: 91.245

8.  Renal scarring after acute pyelonephritis.

Authors:  B Jakobsson; U Berg; L Svensson
Journal:  Arch Dis Child       Date:  1994-02       Impact factor: 3.791

9.  Recurrent urinary tract infections in children: risk factors and association with prophylactic antimicrobials.

Authors:  Patrick H Conway; Avital Cnaan; Theoklis Zaoutis; Brandon V Henry; Robert W Grundmeier; Ron Keren
Journal:  JAMA       Date:  2007-07-11       Impact factor: 56.272

10.  Association of Renal Scarring With Number of Febrile Urinary Tract Infections in Children.

Authors:  Nader Shaikh; Mary Ann Haralam; Marcia Kurs-Lasky; Alejandro Hoberman
Journal:  JAMA Pediatr       Date:  2019-10-01       Impact factor: 16.193

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.